DELRAY BEACH, Fla. & CHASKA, Minn.--(BUSINESS WIRE)--VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that they are expanding their existing development partnership, beyond the glucose-sensing RFID implantable microchip to include other biological and environmental applications, both in combination with RFID technology and without. The partners recently executed a Memorandum of Understanding relating to the expansion.
